ALMS insider buying and SEC filings, explained
Alumis Inc. · CIK 1847367
Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov
Insider activity in the last 12 months
Bought
$61.7M
Insiders who bought
4
Sold (not marked 10b5-1)
$1.4M
Planned sales (10b5-1)
$0
Insider purchases and sales, last 12 months
| Traded | Type | What was filed | Source |
|---|---|---|---|
| Sep 8, 2026 | Sale | Srinivas Akkaraju (Director) sold 96,131 shares indirectly (by entity) at about $10.55 ($1.0M). Holdings by entity down 1% to 4,663,735 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Sep 9, 2026 |
| Sep 4–8, 2026 | Purchase (code P) | Srinivas Akkaraju (Director) bought 986,721 shares indirectly (by entity) between Sep 4 and Sep 8 at about $10.87 ($10.7M), reported as a purchase (code P). Holdings by entity up 11% to 4,937,026 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Sep 9, 2026 |
| Aug 3, 2026 | Sale | Sanam Pangali (Chief Legal Officer) sold 1,364 shares at about $26.37 ($36K). Holdings down 12% to 9,747 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Aug 5, 2026 |
| Aug 3, 2026 | Sale | Mark Christopher Bradley (Chief Development Officer) sold 2,572 shares at about $26.37 ($68K). Holdings down 5% to 48,533 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Aug 5, 2026 |
| Aug 3, 2026 | Sale | Jorn Drappa (Chief Medical Officer) sold 2,447 shares at about $26.37 ($65K). Holdings down 4% to 56,892 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Aug 5, 2026 |
| Aug 3, 2026 | Sale | David M Goldstein (Chief Scientific Officer) sold 2,596 shares at about $26.37 ($68K). Holdings down 8% to 30,970 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Aug 5, 2026 |
| Aug 3, 2026 | Sale | John R. Schroer (CFO) sold 3,282 shares at about $26.37 ($87K). Holdings down 12% to 24,718 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Aug 5, 2026 |
| Aug 3, 2026 | Sale | Roy C. Hardiman (Chief Business & Strategy Ofcr) sold 2,692 shares at about $26.37 ($71K). Holdings down 1% to 207,746 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Aug 5, 2026 |
| Jan 9, 2026 | Purchase (code P) | Srinivas Akkaraju (Director) bought 588,235 shares indirectly (by entity) at $17.00 ($10.0M), reported as a purchase (code P). Holdings by entity up 46% to 1,853,488 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jan 13, 2026 |
| Jan 8, 2026 | Purchase (code P) | Foresite Labs, LLC (10% owner) bought 411,764 shares indirectly at $17.00 ($7.0M), reported as a purchase (code P). Indirect holdings up 16% to 2,908,332 shares. Not marked as a 10b5-1 plan trade. Filed jointly with 1 other reporting owner. | SEC filing Filed Jan 12, 2026 |
| Jan 8, 2026 | Purchase (code P) | Foresite Capital Fund V, L.P. (10% owner) bought 411,764 shares indirectly at $17.00 ($7.0M), reported as a purchase (code P). Indirect holdings up 16% to 2,908,332 shares. Not marked as a 10b5-1 plan trade. Filed jointly with 8 other reporting owners. | SEC filing Filed Jan 12, 2026 |
| Jan 8, 2026 | Purchase (code P) | James B. Tananbaum (Director and 10% owner) bought 411,764 shares indirectly at $17.00 ($7.0M), reported as a purchase (code P). Indirect holdings up 16% to 2,908,332 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jan 12, 2026 |
| Dec 5, 2025 | Purchase (code P) | Srinivas Akkaraju (Director) bought 186,377 shares indirectly (by entity) at about $9.84 ($1.8M), reported as a purchase (code P). Holdings by entity up 17% to 1,265,253 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Dec 9, 2025 |
| Dec 2–4, 2025 | Purchase (code P) | Srinivas Akkaraju (Director) bought 262,027 shares indirectly (by entity) between Dec 2, 2025 and Dec 4, 2025 at about $7.79 ($2.0M), reported as a purchase (code P). Holdings by entity up 32% to 1,078,876 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Dec 4, 2025 |
| Nov 26–Dec 1, 2025 | Purchase (code P) | Srinivas Akkaraju (Director) bought 173,589 shares indirectly (by entity) between Nov 26, 2025 and Dec 1, 2025 at about $7.55 ($1.3M), reported as a purchase (code P). Holdings by entity up 27% to 816,849 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Dec 1, 2025 |
| Nov 21, 2025 | Purchase (code P) | Foresite Capital Fund V, L.P. (10% owner) bought 72,212 shares indirectly at $7.38 ($533K), reported as a purchase (code P). Indirect holdings up 3% to 2,614,215 shares. Not marked as a 10b5-1 plan trade. Filed jointly with 8 other reporting owners. | SEC filing Filed Nov 25, 2025 |
| Nov 21, 2025 | Purchase (code P) | James B. Tananbaum (Director and 10% owner) bought 72,212 shares indirectly at $7.38 ($533K), reported as a purchase (code P). Indirect holdings up 3% to 2,614,215 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Nov 25, 2025 |
| Nov 21, 2025 | Purchase (code P) | Foresite Labs, LLC (10% owner) bought 72,212 shares indirectly at $7.38 ($533K), reported as a purchase (code P). Indirect holdings up 3% to 2,614,215 shares. Not marked as a 10b5-1 plan trade. Filed jointly with 1 other reporting owner. | SEC filing Filed Nov 25, 2025 |
| Nov 20, 2025 | Purchase (code P) | Srinivas Akkaraju (Director) bought 125,743 shares indirectly (by entity) at about $7.20 ($905K), reported as a purchase (code P). Holdings by entity up 24% to 643,260 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Nov 24, 2025 |
| Nov 17–19, 2025 | Purchase (code P) | Srinivas Akkaraju (Director) bought 241,338 shares indirectly (by entity) between Nov 17, 2025 and Nov 19, 2025 at about $6.34 ($1.5M), reported as a purchase (code P). Holdings by entity up 87% to 517,517 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Nov 19, 2025 |
| Nov 17–19, 2025 | Purchase (code P) | Foresite Labs, LLC (10% owner) bought 507,874 shares indirectly between Nov 17, 2025 and Nov 19, 2025 at about $6.09 ($3.1M), reported as a purchase (code P). Indirect holdings up 25% to 2,542,003 shares. Not marked as a 10b5-1 plan trade. Filed jointly with 1 other reporting owner. | SEC filing Filed Nov 19, 2025 |
| Nov 17–19, 2025 | Purchase (code P) | Foresite Capital Fund V, L.P. (10% owner) bought 507,874 shares indirectly between Nov 17, 2025 and Nov 19, 2025 at about $6.09 ($3.1M), reported as a purchase (code P). Indirect holdings up 25% to 2,542,003 shares. Not marked as a 10b5-1 plan trade. Filed jointly with 8 other reporting owners. | SEC filing Filed Nov 19, 2025 |
| Nov 17–19, 2025 | Purchase (code P) | James B. Tananbaum (Director and 10% owner) bought 507,874 shares indirectly between Nov 17, 2025 and Nov 19, 2025 at about $6.09 ($3.1M), reported as a purchase (code P). Indirect holdings up 25% to 2,542,003 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Nov 19, 2025 |
| Nov 13, 2025 | Purchase (code P) | Srinivas Akkaraju (Director) bought 276,179 shares indirectly (by entity) at $5.25 ($1.4M), reported as a purchase (code P). New position of 276,179 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Nov 17, 2025 |
19 routine transactions (such as grants, option exercises or tax withholding) are not listed.
Cluster buys
4 insiders bought in 30 days
$31.0M in purchases since Jan 8, 2026 · Purchases traded Jan 8, 2026 to Jan 9, 2026 · Closed
| Insider | Value | Traded | Source |
|---|---|---|---|
| James B. Tananbaum (Director) | $7.0M | Jan 8, 2026 | SEC filing |
| Foresite Capital Fund V, L.P. (10% owner) | $7.0M | Jan 8, 2026 | SEC filing |
| Foresite Labs, LLC (10% owner) | $7.0M | Jan 8, 2026 | SEC filing |
| Srinivas Akkaraju (Director) | $10.0M | Jan 9, 2026 | SEC filing |
4 insiders bought in 30 days
$20.0M in purchases since Nov 13, 2025 · Purchases traded Nov 13, 2025 to Dec 5, 2025 · Closed
| Insider | Value | Traded | Source |
|---|---|---|---|
| Srinivas Akkaraju (Director) | $1.4M | Nov 13, 2025 | SEC filing |
| James B. Tananbaum (Director) | $3.1M | Nov 19, 2025 | SEC filing |
| Foresite Capital Fund V, L.P. (10% owner) | $3.1M | Nov 19, 2025 | SEC filing |
| Foresite Labs, LLC (10% owner) | $3.1M | Nov 19, 2025 | SEC filing |
| Srinivas Akkaraju (Director) | $1.5M | Nov 19, 2025 | SEC filing |
| Srinivas Akkaraju (Director) | $905K | Nov 20, 2025 | SEC filing |
| Foresite Labs, LLC (10% owner) | $533K | Nov 21, 2025 | SEC filing |
| James B. Tananbaum (Director) | $533K | Nov 21, 2025 | SEC filing |
| Foresite Capital Fund V, L.P. (10% owner) | $533K | Nov 21, 2025 | SEC filing |
| Srinivas Akkaraju (Director) | $1.3M | Dec 1, 2025 | SEC filing |
| Srinivas Akkaraju (Director) | $2.0M | Dec 4, 2025 | SEC filing |
| Srinivas Akkaraju (Director) | $1.8M | Dec 5, 2025 | SEC filing |
Red flags
No red flags in the last 12 months.
Key events
No key events in the last 12 months.
8-K filings, last 12 months
No 8-K filings in the last 12 months.
Red flags are objective triggers only: the item or form filed, never an opinion.
Follow ALMS in the Insider Ledger app
Get the appA plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.